Access to care and the incidence of endstage renal disease due to systemic lupus erythematosus

Journal of Rheumatology

Volumn 37, Issue 6, 2010, Pages 1158-1163

  Ward, Michael M ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Access to care; Endstage renal disease; Socioeconomic status; Systemic lupus erythematosus

Indexed keywords

ADULT; AMBULATORY CARE; ARTICLE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAID; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RURAL AREA; SOCIAL STATUS; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES;

ADULT; CALIFORNIA; COMORBIDITY; FEMALE; HEALTH CARE RATIONING; HEALTH SERVICES ACCESSIBILITY; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEDICAID; MEDICALLY UNINSURED; PATIENT SELECTION; SOCIAL CLASS; UNITED STATES; YOUNG ADULT;

EID: 77953212278     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.091199     Document Type: Article

References (33)

1. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine 2003;82:299-308.
2. Moroni G, Quaglini S, Gallelli B, Banfi G, Messa P, Ponticelli C. The long-term outcome of 93 patients with proliferative lupus nephritis. Nephrol Dial Transplant 2007;22:2531-2539
3. Alarcon GS, McGwin G Jr, Petri M, Ramsey-Goldman R, Fessler BJ, Vila LM, et al. Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort. Plos Med 2006;3:e396.
4. Faurschou M, Starklint H, Halberg P, Jacobsen S. Prognostic factors in lupus nephritis: Diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol 2006;33:1563-1569 (Pubitemid 44168828)
5. Tisseverasinghe A, Lim S, Greenwood C, Urowitz M, Gladman D, Fortin PR. Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus. Arthritis Rheum 2006;54:2211-2219
6. Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, et al. Long-term outcome of diffuse proliferative lupus glomerulone phritis treated with cyclophosphamide. Am J Med 2006;119:355. e25-33.
7. Adler M, Chambers S, Edwards C, Neild G, Isenberg D. An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Rheumatology 2006;45:1144-1147
8. Ward MM. Medical insurance, socioeconomic status, and age of onset of endstage renal disease in patients with lupus nephritis. J Rheumatol 2007;34:2024-2027 (Pubitemid 47548205)
9. Ward MM. Socioeconomic status and the incidence of ESRD. Am J Kidney Dis 2008;51:563-572
10. Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav 1995;36:1-10.
11. US Renal Data System. USRDS 2008 Annual data report: Atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008.
12. Ward MM. Laboratory abnormalities at the onset of treatment of end-stage renal disease: are there racial or socioeconomic disparities in care? Arch Intern Med 2007;167:1083-1091
13. Office of Statewide Health Planning and Development. Editing criteria handbook. Sacramento, CA: Office of Statewide Health Planning and Development; 1995.
14. Romano PS, Mark DH. Bias in the coding of hospital discharge data and its implications for quality assessment. Med Care 1994;32:81-90.
15. Weissman JS, Gatsonis C, Epstein AM. Rates of avoidable hospitalizations by insurance status in Massachusetts and Maryland. JAMA 1992;268:2388-2394
16. Bindman AB, Grumbach K, Osmond D, Komaromy M, Vranizan K, Lurie N, et al. Preventable hospitalizations and access to health care. JAMA 1995;274:305-311
17. Millman M, editor. Access to health care in America. Washington, DC: National Academy Press; 1993.
18. Health Resources and Services Administration. US Department of Health and Human Services, Bethesda, MD. Shortage designation: HPSAs, MUAs, and MUPs. [Internet. Accessed March 15, 2010.] Available from:http://bhpr.hrsa.gov/ shortage/index.htm
19. Economic Research Service, US Department of Agriculture, Washington, DC. Measuring rurality. [Internet. Accessed March 15, 2010.] Available from: http://www.ers.usda.gov/Briefing/Rurality
20. Ward MM. Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995. Arch Intern Med 2000;160:3136-3140
21. Ward MM. Changes in the incidence of endstage renal disease due to lupus nephritis in the United States, 1996-2004. J Rheumatol 2009;36:63-67
22. Fiehn C, Hajjar Y, Mueller K, Waldherr R, Ho AD, Andrassy K. Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment. Ann Rheum Dis 2003;62:435-439
23. Bindman AB, Yoon J, Grumbach K. Trends in physician participation in Medicaid. The California experience. J Ambul Care Manage 2003;26:334-343 (Pubitemid 37158944)
24. Yazdany J, Gillis JZ, Trupin L, Katz P, Panopalis P, Driswell LA, et al. Association of socioeconomic and demographic factors with utilitzation of rheumatology subspecialty care in systemic lupus erythematosus. Arthritis Rheum 2007;57:593-600.
25. Gillis JZ, Yazdany J, Trupin, Julian L, Panopalis P, Criswell LA, et al. Medicaid and access to care among persons with systemic lupus erythematosus. Arthritis Rheum 2007;57:601-607 (Pubitemid 46764049)
26. Fan ZJ, Lackland DT, Lipsitz SR, Nicholas JS, Egan BM, Garvey WT, et al. Geographical patterns of end-stage renal disease incidence and risk factors in rural and urban areas of South Carolina. Health Place 2007;13:179-187
27. Karlson EW, Daltroy LH, Lew RA, Wright EA, Partridge AJ, Fossel AH, et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:47-56.
28. Sutcliffe N, Clarke AE, Gordon C, Farewell V, Isenberg DA. The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology 1999;38:1130-1137 (Pubitemid 29537336)
29. Lotstein DS, Ward MM, Bush TM, Lambert RE, van Vollenhoven R, Neuwelt CM. Socioeconomic status and health in women with systemic lupus erythematosus. J Rheumatol 1998;25:1720-1729 (Pubitemid 28439265)
30. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg MC. Morbidity in systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 1991;91:345-353
31. Adler M, Chambers S, Edwards C, Neild G, Isenberg D. An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25 year period. Rheumatology 2006;45:1144-1147
32. Bruce IN, Gladman DD, Urowitz MB. Factors associated with refractory renal disease in patients with systemic lupus erythematosus: the role of patient nonadherence. Arthritis Care Res 2000;13:406-408
33. Garcia Popa-Lisseanu MG, Greisinger A, Richardson M, O'Malley KJ, Janssen NM, Marcus DM, et al. Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease. J Rheumatol 2005; 32:913-919 (Pubitemid 40676504)